Studies on the mechanism of resistance to rapamycin in human cancer cells

Molecular Pharmacology

Volumn 54, Issue 5, 1998, Pages 815-824

  Hosoi, Hajime ^a,d   Dilling, Michael B ^a   Liu, Linda N ^a   Danks, Mary K ^a   Shikata, Takuma ^a   Sekulic, Aleksander ^b   Abraham, Robert T ^b   Lawrence Jr , John C ^c   Houghton, Peter J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL CYCLE; CHILDHOOD CANCER; CYTOSTASIS; DRUG MECHANISM; GENE INDUCTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NEUROBLASTOMA; ONCOGENE C MYC; PRIORITY JOURNAL;

EID: 0031755688     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.5.815     Document Type: Article

References (35)

1. Brown EJ, Albers MW, Shin TB, Ocjlawa K, Keith CT, Lane WS, and Schreiber SL (1994) A mammalian protein targeted by G1-arresting rapamycin receptor complex. Nature (Lond) 369:756-758.
2. Brunn GJ, Hudson CC, Sekulic A, Williams, JM, Hosoi H, Houghton PJ, Lawrence JC, and Abraham RT (1997) Phosphorylation of the eukaryotic initiation factor-4E-binding protein, PHAS-I, by the mammalian target of rapamycin. Science (Washington DC) 277:99-104.
3. Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence JC Jr, and Abraham RT (1996) Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO (Eur Mol Biol Organ) J 15:5256-5267.
4. Burnett PE, Barrow RK, Cohen NA, and Snyder SH (1998) RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BPI. Proc Natl Acad Sci USA 95:1432-1437.
5. Chiu MI, Katz H, and Berlin V (1994) RAPT1, a mammalian homolog of yeast TOR interacts with the FKBP/rapamycin complex. Proc Natl Acad Sci USA 91:12574-2578.
6. DeBenedetti A, Joshi B, Graff JR, and Zimmer SG (1994) CHO cells transformed by the translation factor eIF4E display increased c-myc expression but require overexpression of Max for tumorigenicity. Mol Cell Differ 2:347-371.
7. Dennis PB, Pullen N, Kozma SC, and Thomas G (1996) The principal rapamycin-sensitive p70S6k phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases. Mol Cell Biol 16:6242-6251.
8. Dias P, Parham DM, Shapiro DN, Tapscott SJ, and Houghton PJ (1992) Monoclonal antibodies to the myogenic regulatory protein MyoDI: epitope mapping and diagnostic utility. Cancer Res 52:6431-6439.
9. Dilling MB, Dias P, Shapiro DN, German GS, Johnson RK, and Houghton PJ (1994) Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor. Cancer Res 54:903-907.
10. El-Badry OM, Minniti C, Kohn EC, Houghton PJ, Daughaday WH, and Helman LJ (1990) Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. Cell Growth Differ 1:325-331.
11. El-Badry OM, Romanus JA, Helman LJ, Cooper MJ, Rechler MM, and Israel MA (1989) Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J Clin Invest 84:829-839.
12. Flanagan WM, Carthésy B, Bram RJ, and Crabtree JR (1991) Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature (Lond) 352:803-807.
13. Fruman DA, Klee CB, Bierer BE, and Burakoff SJ (1992) Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci USA 89:3686-3690.
14. Gingras A-C, Kennedy SG, O'Leary MA, Sonenberg N, and Hay N (1998) 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt (PKB) signaling pathway. Genes Deu 12:502-513.
15. Hara K, Yonezawa K, Kozlowski MT, Sugimoto T, Andrabi K, Weng QP, Kasuga M, Nishimoto I, and Avruch J (1997) Regulation of eIF-4E BPI phosphorylation by mTOR. J Biol Chem 272:26457-26463.
16. Houghton PJ, Bailey FC, Germain GS, Grindey GB, Howbert JJ, and Houghton JA (1990) Studies on the cellular pharmacology of N-(4-methylphenylsulfonyl)-N′-(4-chlorphenyl)-urea. Biochem Pharmacol 39:1187-1192.
17. Jeffries HBJ, Reinhard C, Kozma SC, and Thomas G (1994) Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc Natl Acad Sci USA 91:4441-4445.
18. Kunz J and Hall MN (1993) Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. Trends Biochem Sci 18:334-338.
19. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, and Schreiber SL (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807-815.
20. McCaffrey PG, Luo C, Kerpola TK, Jain J, Badalian TM, Ho AM, Burgeon E, Lane WS, Lambert JN, Curran T, Verdine GL, Rao A, and Hogan PG (1993) Isolation of the cyclosporin-sensitive T-cell transcription factor NFATp. Science (Washington DC) 262:750-754.
21. Nielsen FC, Ostergaard L, Nielsen J, and Christiansen J (1995) Growth-dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway. Nature (Lond) 377:358-362.
22. Pearson RB, Dennis PB, Han JW, Williamson NA, Kozma SC, Wettenhall REH, and Thomas G (1995) The principal target of rapamycin-induced p70S6K inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO (Eur Mol Biol Organ) J 14:5279-5287.
23. Pullen N, Dennis PB, Andjelkovic M, Dufner A, Kozma SC, Hemmings BA, and Thomas G (1998) Phosphorylation and activation of p70S6K by PDK1. Science (Washington DC) 279:707-710.
24. Rosenwald IB, Kaspar R, Rousseau D, Gehrke L, Leboulch P, Chen JJ, Schmidt EV, Sonenberg N, and London IM (1995) Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and posttranscriptional levels. J Biol Chem 270:21176-21180.
25. Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P, and Snyder SH (1994) RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78:35-43.
26. Schreiber SL (1991) Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science (Washington DC) 251:283-287.
27. Senderowicz AM, Carlson BA, Malspies L, Sauseville EA, and Worland PJ (1995) Rapamycin induces Rb hypophosphorylation and G1/S block in the PC3 prostate carcinoma cell line. Proc Am Assoc Cancer Res 36:2360A.
28. Siekierka JJ, Hung SHY, Poe M, Lin CS, and Sigal NH (1989) A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature (Lond) 341:755-757.
29. Shantz LM and Pegg AE (1994) Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cancer Res 54:2313-2316.
30. Shapiro DN, Jones BG, Shapiro LH, Dias P, and Houghton PJ (1994) Anti-sense-mediated reduction in insulin-like growth factor-1 receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J Clin Invest 94:1235-1242.
31. Terada N, Franklin RA, Lucas JJ, Blenis J, and Gelfand EW (1993) Failure of rapamycin to block proliferation once resting cells have entered the cell cycle despite inactivation of p70 S6 kinase. J Biol Chem 268:12062-12068.
32. Terada N, Patel HR, Takase K, Kohno K, Nairn AC, and Gelfand EW (1994) Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proc Natl Acad Sci USA 91:11477-11481.
33. von Manteuffel SR, Dennis PB, Pullen N, Gingras A-C, Sonenberg N, and Thomas G (1997) The insulin-induced signaling pathway leading to S6 and initiation factor 4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70S6K. Mol Cell Biol 17:5426-5436.
34. von Manteuffel SR, Gingras AC, Ming XF, Sonenberg N, and Thomas G (1996) 4E-BPI phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase. Proc Natl Acad Sci USA 93:4076-4080.
35. West MJ, Stonely M, and Willis AE (1998) Translational induction of the c-myc oncogene via activation of the FRAP/TOR signalling pathways. Oncogene 17:769-780.